Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
US Army
Express Scripts
AstraZeneca
QuintilesIMS
Harvard Business School
Farmers Insurance
Cipla
Cantor Fitzgerald

Generated: October 21, 2017

DrugPatentWatch Database Preview

TETRABENAZINE Drug Profile

« Back to Dashboard

What is the patent landscape for Tetrabenazine, and what generic Tetrabenazine alternatives are available?

Tetrabenazine is a drug marketed by Sun Pharma Global, Hetero Labs Ltd V, Apicore Us, and Actavis Labs Fl Inc. and is included in four NDAs.

The generic ingredient in TETRABENAZINE is tetrabenazine. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.

Summary for Tradename: TETRABENAZINE

US Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list5
Bulk Api Vendors: see list56
Clinical Trials: see list11
Patent Applications: see list1,227
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TETRABENAZINE at DailyMed

Pharmacology for Tradename: TETRABENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
TETRABENAZINE
tetrabenazine
TABLET;ORAL206129-001Aug 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TETRABENAZINE
tetrabenazine
TABLET;ORAL206686-001Jul 7, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
TETRABENAZINE
tetrabenazine
TABLET;ORAL204574-002Feb 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma Global
TETRABENAZINE
tetrabenazine
TABLET;ORAL206129-002Aug 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
TETRABENAZINE
tetrabenazine
TABLET;ORAL204574-001Feb 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Apicore Us
TETRABENAZINE
tetrabenazine
TABLET;ORAL207682-002Jan 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Apicore Us
TETRABENAZINE
tetrabenazine
TABLET;ORAL207682-001Jan 31, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Cipla
US Department of Justice
Julphar
McKesson
Deloitte
Harvard Business School
Citi
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot